Daily Roundup

DRO.ASX MVF.ASX VNT.ASX EVT.ASX CU6.ASX

A Busy Day in the Markets: Key Announcements You Need to Know

DroneShield Secures $6.2 Million Asia Pacific Contract DroneShield Limited (ASX:DRO) has landed a significant $6.2 million contract from a military end-customer in the Asia Pacific region. This is part of an ongoing relationship with a reseller, with the company receiving 14 previous contracts worth over $48 million in the past 2 years. Delivery and payment for this latest deal are expected in 2026.

Monash IVF Consortium Withdraws Acquisition Proposal In a surprising turn of events, the consortium comprising Genesis Capital and WHSP Holdings has withdrawn its non-binding indicative proposal to acquire Monash IVF Group Limited (ASX:MVF) at $0.80 per share. Monash IVF will keep shareholders informed of any future material developments.

Ventia Secures Major NSW Cleaning Contract Ventia Services Group Ltd (ASX:VNT) has been awarded the NSW Whole-of-Government Cleaning Services contract for the Western Sydney region. The approximately $100 million, 18-month contract with a one-year extension option reinforces Ventia's position as a trusted partner for the NSW government.

EVT Expands Hotel Portfolio with QT Auckland Acquisition EVT Limited (ASX:EVT) has announced the $87.5 million acquisition of the premium QT Auckland hotel. This strategic move aligns with EVT's plan to grow its hotels division, with the QT brand now having a presence in key cities across Australia, New Zealand, and Singapore.

Clarity Pharma's PSMA Imaging Tech Gains Spotlight Clarity Pharmaceuticals (ASX:CU6) has had an abstract on its Co-PSMA Investigator-Initiated Trial accepted for oral presentation at the prestigious European Association of Urology (EAU) Congress 2026. The trial demonstrated that Clarity's 64Cu-SAR-bisPSMA PET/CT outperformed the standard-of-care 68Ga-PSMA-11 in detecting more lesions in prostate cancer patients.

It's been a busy day with a diverse range of announcements across several industries. From major contract wins and strategic acquisitions to advancements in medical technology, these updates showcase the dynamic nature of the Australian business landscape. Stay tuned for more insights as the market continues to evolve.